Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Frameshift Peptides of Children With Neurofibromatosis Type 1 (NF1) and Either Low-Grade Gliomas or Plexiform Neurofibromas

NCT04212351 is registered in ClinicalTrials.gov with Children's National Research Institute as lead sponsor.

NCT NCT04212351
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04212351 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Frameshift Peptides of Children With Neurofibromatosis Type 1 (NF1) and Either Low-Grade Gliomas or Plexiform Neurofibromas
Lead sponsor
Children's National Research Institute
Phase
Observational
Overall status
Completed
Start date
April 11, 2019
Completion date
April 27, 2022
Enrollment
60 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

neurofibromatosis type 1